Skip to main content
Clinical Trials/NCT03335150
NCT03335150
Completed
N/A

Cognitive Rehabilitation for Individuals With Parkinson's Disease and MCI

VA Office of Research and Development1 site in 1 country110 target enrollmentNovember 2, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
VA Office of Research and Development
Enrollment
110
Locations
1
Primary Endpoint
Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To investigate the effectiveness of a novel compensatory cognitive rehabilitation program for individuals with Parkinson's disease (PD) and mild cognitive impairment (MCI).

Detailed Description

Eligible study participants will be randomly assigned to one of two interventions: 1) Cognitive Rehabilitation (Cognitive Symptom Management and Rehabilitation Therapy for Parkinson's disease; CogSMART-PD) or 2) Supportive Care. Interventions are held within a group format consisting of approximately 5 individuals with PD. Groups will meet once per week for 1.5 hours over a 10-week period. Neuropsychological testing will be administered pre- and post-intervention as well as 6- and 12-months after the intervention.

Registry
clinicaltrials.gov
Start Date
November 2, 2015
End Date
January 31, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Parkinson's disease
  • Mild Cognitive Impairment
  • Over 40 years of age
  • Fluent English speaker

Exclusion Criteria

  • Other neurological conditions (e.g., stroke) besides Parkinson's disease

Outcomes

Primary Outcomes

Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score

Time Frame: Baseline and Week 10

The WAIS-IV Matrix Reasoning test is a validated, objective measure of executive function. Scaled scores range from 0 to 26. Higher scores indicate better executive function. Scores reported below are change scores.

Secondary Outcomes

  • Cognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use Score(Baseline and Week 10)
  • Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total Score(Baseline and Week 10)
  • Memory for Intention Test (MIST) Total Score(Baseline and Week 10)
  • World Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed Score(Baseline and Week 10)
  • Delis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled Score(Baseline and Week 10)
  • Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score(Baseline and Week 10)
  • Neuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month Score(Baseline and Week 10)
  • Informant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total Score(Baseline and Week 10)

Study Sites (1)

Loading locations...

Similar Trials